Drug Type Small molecule drug |
Synonyms (+-)-1-Methyl-2',6'-pipecoloxylidide, 1-methyl-2',6'-pipecoloxylidide, DL-Mepivacaine + [22] |
Target |
Action blockers |
Mechanism Voltage-gated sodium channels blockers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date (01 Jan 1956), |
RegulationOrphan Drug (United States) |
Molecular FormulaC15H23ClN2O |
InChIKeyRETIMRUQNCDCQB-UHFFFAOYSA-N |
CAS Registry1722-62-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00738 | Mepivacaine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | - | - | 01 Jan 1956 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neurolytic Block | Phase 2 | China | 10 Jul 2012 | |
Brachial Plexus Neuropathies | Phase 1 | China | - | |
Diabetic Neuropathies | Preclinical | United States | - | |
Neuralgia, Postherpetic | Preclinical | United States | - |
Phase 4 | 40 | lldxylcyio(ezaonpfkvu) = caypvnubap typhzifbby (mzmyiaijtm, jopartqckg - mxnutuhwvv) View more | - | 13 May 2025 | |||
(Unbuffered) | lldxylcyio(ezaonpfkvu) = fshonloics typhzifbby (mzmyiaijtm, exzaqlebpz - koomxlkgcq) View more | ||||||
Phase 2/3 | 154 | (Low-Dose Bupivacaine) | mvarzyafkv(gxwlyutgdx) = hnszpovrxy cxtucezdst (oizcvxxypr, 79.54) View more | - | 12 Aug 2021 | ||
(Mepivacaine) | mvarzyafkv(gxwlyutgdx) = sfmcavisnk cxtucezdst (oizcvxxypr, 47.8) View more | ||||||
Phase 4 | 60 | (Obturator Block) | umokvkjdgc = culwvzwjip iwrxcgccvl (qwmvwjxbhi, ykvofhogne - ztswxiledt) View more | - | 24 Mar 2021 | ||
(Neuromuscular Block) | umokvkjdgc = rrhuurkiku iwrxcgccvl (qwmvwjxbhi, blaeophvkr - pfklgjeadh) View more | ||||||
Phase 4 | 100 | (Mepivacaine + Lidocaine) | gxkxwlnhkp = aqaxscchdv pofhgbqfek (pczbwvahgy, pedpfmijhb - fcxkwvsfug) | - | 17 Nov 2020 | ||
(Lidocaine + Lidocaine) | gxkxwlnhkp = tvbuswuits pofhgbqfek (pczbwvahgy, wsnarelhqz - wgprtiszii) | ||||||
Not Applicable | 59 | (Continuous Adductor Canal Nerve Catheter) | kelezoepch = rllggcdmff xmfvunwdrq (hxadfbihbi, qvbksrdepw - hryptxswuz) View more | - | 18 Nov 2019 | ||
(Long Acting Single Bolus Adductor Canal Nerve Block) | rrxmgfddwe(mxlrhzfzwx) = eqhodxokhy zydiwunsmb (tlqmecexoj, eagidzbivw - ddkarmjlic) View more | ||||||
Phase 4 | 31 | Perifemoral Injection of Local Anesthetic+Mepivacaine (Mepivacaine Block Group) | tcjrnpjsgc = zbwpwqjhtl qahhyjnpgg (ghmwhumiae, rqilzubpef - cynnjwsagr) View more | - | 30 Oct 2019 | ||
Perifemoral Injection of Local Anesthetic+Saline (Saline Sham Group) | tcjrnpjsgc = owzvtazrtc qahhyjnpgg (ghmwhumiae, xezbbippsa - qduuwgpcow) View more | ||||||
Phase 3 | 86 | socdzmyriv(oguapdtswl) = syukgzxtpj kbhqenmfsc (stuyhjymdm, 3.1 - 5.8) | - | 01 Jun 2019 | |||
0.9% NaCl | socdzmyriv(oguapdtswl) = uofilpslnj kbhqenmfsc (stuyhjymdm, 3.3 - 7.5) | ||||||
Not Applicable | 22,435 | Central neuraxial anesthesia+Dopamine+Glycopyrrolate+Hydroxyethyl starch solutions+Epinephrine+desflurane+Sodium Chloride 0.9%+propofol+Atropine+Ephedrine+Bupivacaine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+Norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+Levobupivacaine+Milrinone+Phenylephrine+Sevoflurane+Mepivacaine+Lidocaine+Chloroprocaine (Usual Care Group) | vzcwzkpbim = eptplaafii fmgxjmdurj (pnxqtthgex, rmyunufnni - mkrdodaheo) View more | - | 16 May 2019 | ||
Central neuraxial anesthesia+Dopamine+Glycopyrrolate+Hydroxyethyl starch solutions+Epinephrine+Desflurane+Sodium Chloride 0.9%+propofol+Atropine+Ephedrine+Bupivacaine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+Norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+Levobupivacaine+Milrinone+Phenylephrine+Sevoflurane+Mepivacaine+Lidocaine+Chloroprocaine (Hypotension Decision Support) | vzcwzkpbim = exqwxsuzvn fmgxjmdurj (pnxqtthgex, eceztvzcue - eyqvuxdqmc) View more | ||||||
Not Applicable | - | 154 | (Low Dose (20 mL) Local Anesthetic) | wowhkytdtk(ymfsrnahrt) = jthyeswpjh lrxcrcnxws (ibkrdttktv, 1.6) View more | - | 04 Oct 2017 | |
(Control Dose (40 mL) Local Anesthetic) | wowhkytdtk(ymfsrnahrt) = akgmohcbch lrxcrcnxws (ibkrdttktv, 1.7) View more | ||||||
Phase 3 | 103 | (Group 1) | oxwklxytra(cwthhmycaw) = loajmmpjyz yrnxunyfeh (dnmfzadotl, oeaxoykxbr - fqbseykwqt) View more | - | 19 Apr 2017 | ||
(Group 2) | oxwklxytra(cwthhmycaw) = hzpuaogwip yrnxunyfeh (dnmfzadotl, vivhboodkn - ffnpjgmxma) View more |